Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADIPRAT: Tocilizumab in RA
NCT02843789Phase 4Completed
- Sponsor
- CHU de Besançon
- Start
- Mar 2013
- Primary completion
- Nov 2017
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by CHU de Besançon. Started Mar 2013; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02843789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843789.